News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Bladder preservation possible in select MIBC patients
29 Dec 2025
byStephen Padilla
Neoadjuvant chemotherapy (NAC) with transurethral resection (TUR) for bladder preservation is feasible for some patients with muscle-invasive bladder cancer (MIBC) who meet established selection criteria, suggests a study. However, recurrence may occur beyond 10 years, warranting lifetime surveillance.
Bladder preservation possible in select MIBC patients
29 Dec 2025
Pharmacogenomics combines pharmacology and genomics to better understand how genetic differences influence individual responses to medications.
26 Dec 2025
bySaras Ramiya, Senior Editor, MPF
Genetic makeup may be the reason why some medicines function for some people but not others.







